This page uses content from Wikipedia and is licensed under CC BY-SA.


Clinical data
Trade namesManyper, etc.
AHFS/Drugs.comInternational Drug Names
Routes of
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
Molar mass610.69 g/mol g·mol−1
3D model (JSmol)

Manidipine is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive.[1][2][3][4][5]

It was patented in 1982 and approved for medical use in 1990.[6]


  1. ^ Cheer, S.M.; McClellan, K. (2001), "Manidipine: A Review of its Use in Hypertension", Drugs, 61 (12): 1777–99, doi:10.2165/00003495-200161120-00010, PMID 11693466, archived from the original on 2013-01-17, retrieved 2009-06-20
  2. ^ McKeage, K.; Scott, L.J. (2004), "Manidipine: A Review of its Use in the Management of Hypertension", Drugs, 64 (17): 1923–40, doi:10.2165/00003495-200464170-00011, PMID 15329044, archived from the original on 2013-01-16, retrieved 2009-06-20
  3. ^ Roca-cusachs, A.; Triposkiadis, F. (2005), "Antihypertensive Effect of Manidipine", Drugs, 65: 11–9, doi:10.2165/00003495-200565002-00003, PMID 16398058, archived from the original on 2013-01-16, retrieved 2009-06-20
  4. ^ Otero, M.L. (2007), "Manidipine–delapril combination in the management of hypertension", Vascular Health and Risk Management, 3 (3): 255–63, PMC 2293964, PMID 17703633
  5. ^ Mizuno, Kenji; Haga, Hiroshi; Takahashi, Michihiko; Fukuchi, Soitsu (August 1992), "Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders", Current Therapeutic Research, 52 (2): 248–253, doi:10.1016/S0011-393X(05)80475-8, retrieved 2009-06-20[dead link]
  6. ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 465. ISBN 9783527607495.